6-KThe Wire
YD Bio Ltd files 6-K
Filed Feb 26, 2026 · 5mo ago · Accession 0001213900-26-020678
Plain English
YD Bio Limited announced a strategic partnership between its subsidiary, YD Bio USA, Inc., and YC Biotech Co., Ltd. to create a "Taiwan-U.S. Dual-Core" regulatory platform for U.S. Food and Drug Administration (FDA) submissions. This partnership will involve YD Bio USA serving as YC Biotech's exclusive U.S. Agent and liaison with the FDA for its Asian Contract Research Organization clients.
Filing details
- Company
- YD Bio Ltd
- Ticker
- YDES
- CIK
- 2011674
- Form type
- 6-K
- Filing date
- Feb 26, 2026
- Report date
- Feb 26, 2026
- Document
- ea0278346-6k_ydbio.htm
- Size
- 31 KB